Investing in Invivyd: Building Confidence in the Future of Biopharmaceuticals
On September 12, 2023, it was revealed that Bain Capital Life Sciences Investors LLC had acquired a new stake in ...
Tag: IVVD
Aristotle Capital Boston LLC Increases Stake in Wolverine World Wide as Experts Remain Cautiously Optimistic
Aristotle Capital Boston LLC, a prominent investment firm, has increased its stake in Wolverine World Wide, Inc. (NYSE:WWW) by 5.5% ...
Invivyds Share Prices Dip as Investors Cash In on AfterHours Surge
Invivyd's share prices have taken a dip, potentially due to investors cashing in on their profits as the stock retreats ...
Invivyd Inc Announces Second Quarter Financial Performance and Discusses Future Strategies
Invivyd, Inc. revealed its financial performance for the second quarter ended June 30, 2023, announcing a net loss of $50.2 ...
Invivyd, Inc: Anticipating Earnings Report and Promising Future in Infectious Disease Management
Invivyd, Inc (NASDAQ: IVVD), a clinical-stage biopharmaceutical company, is eagerly anticipated to release its earnings data on Thursday, August 10th, ...
Director at Invivyd Granted Stock Options Insight into Insider Transactions in the Health Care Sector
On May 25, 2023, Clive Meanwell, the Director at Invivyd, was granted stock options that amount to 50,000 shares of ...
Insider Acquisition of Stock Options at Invivyd
On May 26, 2023, Terrance McGuire, a member of the board at Invivyd, made an acquisition of stock options worth ...
Invivyd Reports Q1 Losses Misses Analyst Estimate
Invivyd (NASDAQ: IVVD) has recently released its Q1 earnings report, indicating a quarterly loss of $(0.32) per share. This figure ...